Sanofi announced the appointment of Rachid Ayari as the Interim Managing Director, in addition to his current role as the Chief Financial Officer (CFO) for a term of six months from 21 July 2025.
“Appointment for a term of 6 months from 21st July 2025 to 20th January 2026 or until a Permanent Managing Director is appointed, whichever is earlier. There shall be no change in the terms and conditions of his appointment,” Sanofi India mentioned in the regulatory filing.
This appointment comes after Sanofi’s former MD, Rodolfo Hrosz, stepped down from his role in April to take up another position within the French pharma company.
With over 8 years of experience at Sanofi, following a 16-year tenure at Pfizer, Rachid Ayari bring a wealth of knowledge in major finance fields and a diverse international background, having worked across various countries as CFO from North Africa to Russia & Central Asia and finally India. His expertise extends to financial management, working closely with cross-functional teams, and ensuring compliance with regulatory and corporate standards
